Case Study: a Korea-based Biotechnology Manufacturer Achieves Successful BLA Submission and LATAM/APAC Product Registration with FREYR

Korea-based Biotechnology Manufacturer submits BLA and expands to LATAM/APAC with FREYR

FREYR provided regulatory support to a Korea-based biotechnology manufacturer that needed assistance in preparing and submitting a Biologics License Application (BLA) for the U.S. market. The client faced challenges in developing a regulatory strategy for subsequent market expansion into LATAM and APAC regions and in generating data that complied with USFDA standards.

FREYR's solution involved preparing the CTD and BLA submission, conducting a gap analysis of CMC data, and creating a country-specific submission strategy for target markets. FREYR successfully supported the BLA submission in the USA and the timely submission of product registration dossiers in multiple LATAM and APAC countries, executing the project within the agreed timelines.